Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP

Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP

Objective: Limited data about the prognostic significance of BCL2 mutations and BCL2 copy number variations in diffuse large B-cell lymphoma (DLBCL) are available. This study aimed to comprehensively describe BCL2 genetic alterations in DLBCL patients, and examine correlation of BCL2, TP53 and other...

Full description

Bibliographic Details
Main Authors: Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang, Yuankai Shi
Format: Article
Language:English
Published: China Anti-Cancer Association 2022-06-01
Series:Cancer Biology & Medicine
Subjects:
bcl2
tp53
genetic alterations
diffuse large b-cell lymphoma
prognosis
Online Access:https://www.cancerbiomed.org/content/19/6/893

Internet

https://www.cancerbiomed.org/content/19/6/893

Similar Items